<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997007/" ref="ordinalpos=5033&amp;ncbi_uid=2620896&amp;link_uid=PMC2997007" image-link="/pmc/articles/PMC2997007/figure/F6/" class="imagepopup">Figure 6.  From: Differential functional genomic effects of anti-inflammatory phytocompounds on immune <span class="highlight" style="background-color:">signaling</span>. </a></div><br /><div class="p4l_captionBody"><b>Identification of putative signaling regulators for immune-modification</b>. Key node analysis in the TRANSPATH database for putative unique signaling master regulator/molecule at 0.5 h with significant inhibition of expression (≥3-fold decrease) in LPS-induced THP-1 cells co-treated with <b>(A) </b>shikonin, <b>(B) </b>emodin, or <b>(C) </b>BF/S+L/Ep at 12 h. Less than four hierarchical levels of regulation were accepted and selected. Pink circle: the putative master regulator/molecule; green box: the ratio of gene expression seen with the phytocompounds plus LPS compared to LPS only; gray circle: assigned molecule in the putative pathway; <b>↑</b>: activation; <b>⊥</b>: inhibition.</div></div>